Consistent with these preclinical findings, analysis of RCC patient datasets from TCGA revealed a positive association between IL-6 levels and immunosuppressive cells, such as Tregs, MDSCs, and cancer-associated fibroblasts. This evidence concerns the gene IL6 and cancer.